Literature DB >> 23352316

Blockade of ventral midbrain NMDA receptors enhances brain stimulation reward: a preferential role for GluN2A subunits.

Sabrina Bergeron1, Pierre-Paul Rompré.   

Abstract

Ventral midbrain (VM) neurons that project to limbic structures play a role in reward and incentive motivation. It has been suggested that a reward-related signal is transmitted when the firing rate of VM dopamine neurons shifts from a tonic to a phasic mode. Since glutamate is necessary for this transduction process, it is likely to play a role in reward signaling. This study was aimed at determining the effect of VM N-Methyl-D-Aspartate (NMDA) receptor blockade on reward induced by electrical brain stimulation. Experiments were performed on rats trained to self-administer an electrical stimulation in the medial posterior mesencephalon. Reward thresholds were measured with the curve-shift paradigm before and after bilateral VM injections of the following NMDA receptor antagonists: R-CPP, 3-(R-2-Carboxypiperazin-4-yl)-propyl-1 phosphonic acid, (0, 20.6, 41.2 and 82.5 pmol/0.5 μl/side), PPPA, (2R,4S)-4-(3-Phosphonopropyl)-2-piperidinecarboxylic acid, (0, 0.825 and 1.65 nmol/0.5 μl/side) orRo04-5595, 1-[2-(4-Chlorophenyl)ethyl]-1,2,3,4-tetrqahydro-6-methoxy-2-methyl-7-isoquinolinol hydrochloride (0, 0.825, 1.65 nmol/0.5 μl/side). R-CPP and PPPA produced a dose and time dependent decrease in reward threshold, an effect that was, at some doses and times after the injection, accompanied by an increase in maximum responses. These effects were not observed with Ro04-5595 over the range of doses tested. While previous studies suggest a role for glutamate in reward signaling, the present results show that VM glutamate exerts a tonic inhibition on the reward-relevant pathway. The selectivity of Ro04-5595 for NMDA receptors composed of GluN2B subunits and the higher affinity of R-CPP and PPPA for GluN2A suggest that the inhibition is mediated by receptors composed of GluN2A subunits.
Copyright © 2013 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  GluN2A; GluN2B; Glutamate; NMDA; Reward; Ventral midbrain

Mesh:

Substances:

Year:  2013        PMID: 23352316     DOI: 10.1016/j.euroneuro.2012.12.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  7 in total

Review 1.  Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.

Authors:  Nebojsa Nick Knezevic; Ajay Yekkirala; Tony L Yaksh
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

2.  Reduction in Ventral Midbrain NMDA Receptors Reveals Two Opposite Modulatory Roles for Glutamate on Reward.

Authors:  Giovanni Hernandez; Ali Khodami-Pour; Daniel Lévesque; Pierre-Paul Rompré
Journal:  Neuropsychopharmacology       Date:  2015-01-12       Impact factor: 7.853

3.  CPP impairs contextual learning at concentrations below those that block pyramidal neuron NMDARs and LTP in the CA1 region of the hippocampus.

Authors:  Kurt Laha; Mengwen Zhu; Erin Gemperline; Vinuta Rau; Lingjun Li; Michael S Fanselow; Richard Lennertz; Robert A Pearce
Journal:  Neuropharmacology       Date:  2021-10-20       Impact factor: 5.273

4.  Repeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: A role for NMDA receptors.

Authors:  David Voyer; Daniel Lévesque; Pierre-Paul Rompré
Journal:  Neuropharmacology       Date:  2016-06-05       Impact factor: 5.250

Review 5.  To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making.

Authors:  Giovanni Hernandez; Joseph F Cheer
Journal:  Front Behav Neurosci       Date:  2015-12-17       Impact factor: 3.558

6.  Opposite modulation of brain stimulation reward by NMDA and AMPA receptors in the ventral tegmental area.

Authors:  Charles Ducrot; Emmanuel Fortier; Claude Bouchard; Pierre-Paul Rompré
Journal:  Front Syst Neurosci       Date:  2013-10-03

7.  Ventral Midbrain NMDA Receptor Blockade: From Enhanced Reward and Dopamine Inactivation.

Authors:  Giovanni Hernandez; Marie-Pierre Cossette; Peter Shizgal; Pierre-Paul Rompré
Journal:  Front Behav Neurosci       Date:  2016-08-26       Impact factor: 3.558

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.